Vlado Perkovic's Publications

• Canagliflozin and cardiovascular and renal events in type 2 diabetes

  Journal articles

  2017

  New England Journal of Medicine

• Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: The TESTING randomized clinical trial

  Journal articles

  2017

  JAMA - Journal of the American Medical Association

• Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST)

  Journal articles

  2017

  New England Journal of Medicine

• Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: A systematic review and meta-analysis

  Journal articles

  2017

  JAMA - Journal of the American Medical Association

• Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial

  Journal articles

  2017

  Nephrology

• Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials

  Journal articles

  2017

  Diabetes, Obesity and Metabolism

• CARMELINA (R) Trial Baseline Characteristics: A Cardiovascular and Renal Microvascular Outcome Trial with Linagliptin in Patients with Type 2 Diabetes at High Vascular Risk

  Conference Papers

  2017

  DIABETES

• Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation

  Journal articles

  2017

  American Journal of Kidney Diseases

• Chronic kidney disease in Asia: Protocol for a collaborative overview

  Journal articles

  2017

  Nephrology

• A trial of extending hemodialysis hours and quality of life

  Journal articles

  2017

  Journal of the American Society of Nephrology

• EFFECTS OF EMPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME (R) TRIAL

  Conference Papers

  2017

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• EFFECTS OF EMPAGLIFLOZIN ON RENAL OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME (R) TRIAL

  Conference Papers

  2017

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• SO019EFFECTS OF EMPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME TRIAL

  Journal articles

  2017

  Nephrology Dialysis Transplantation

• SP259EFFECTS OF EMPAGLIFLOZIN ON RENAL OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME TRIAL

  Journal articles

  2017

  Nephrology Dialysis Transplantation

• The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy

  Journal articles

  2017

  Diabetes, Obesity and Metabolism

• Comparison of exposure response relationship of atrasentan between North American and Asian populations

  Journal articles

  2017

  Diabetes, Obesity and Metabolism

• Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment StudyRenal (CANVAS-R): A randomized, placebo-controlled trial

  Journal articles

  2017

  Diabetes, Obesity and Metabolism

• Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients

  Journal articles

  2017

  Cochrane Database of Systematic Reviews

• Chronic kidney disease and the global NCDs agenda

  Journal articles

  2017

  BMJ Global Health

• Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis

  Journal articles

  2017

  American Journal of Kidney Diseases

• Canagliflozin slows progression of renal function decline independently of glycemic effects

  Journal articles

  2017

  Journal of the American Society of Nephrology

• Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: An analysis of the PROGRESS and ADVANCEtrials

  Journal articles

  2017

  Journal of Hypertension

• Commentary

  Journal articles

  2016

  Annals of Internal Medicine

• Management of patients with diabetes and CKD:conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Journal articles

  2016

  Kidney International

• A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension

  Journal articles

  2016

  The Lancet

• The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis

  Journal articles

  2016

  American Journal of Kidney Diseases